Concepedia

Eric M. Maiese

EM

Statistics

Publications

15

Citations

488

H-Index

12

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Janssen (United States)

Johns Hopkins University

Janssen Scientific Affairs (United States)

GlaxoSmithKline (United States)

Eric M. Maiese is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, aids pathogenesis, and physical therapy.

Top concepts

Publications per year

2005–2022

15

Publications

15

Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma

Rafaël Fonseca, Saad Z. Usmani, Maneesha Mehra et al. · BMC Cancer · 2020 · 108 citations · Full text

Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study

Leif Saager, Eric M. Maiese, Lori D. Bash et al. · Journal of Clinical Anesthesia · 2018 · 100 citations

, , +11

Daratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens: Efficacy in transplant‐ineligible untreated myeloma

Brian G.M. Durie, Shaji Kumar, Saad Z. Usmani et al. · American Journal of Hematology · 2020 · 41 citations · Full text

, , +16

Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.

Jonathan D. Campbell, Felicia Allen‐Ramey, Shiva G. Sajjan et al. · PubMed · 2011 · 38 citations

Polymorphisms in Cytokine Genes and Risk of <i>Helicobacter pylori</i> Infection among Jamaican Children

Fan‐Chen Tseng, Elizabeth E. Brown, Eric M. Maiese et al. · Helicobacter · 2006 · 35 citations

1–5 of 15